Newsroom

Literature

Preliminary results of the Liquid Biopsy for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS) study

EACR 2022
Presented
Jun 20, 2022
Type
Poster

Leveraging personalized circulating tumor DNA (ctDNA) for detection and monitoring of molecular residual disease in high-risk melanoma

ASCO 2022
Presented
Jun 6, 2022
Type
Poster

Liquid Biopsy for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS): A personalized cell-free tumor DNA analysis for patients with HNSCC

ASCO 2022
Presented
Jun 6, 2022
Type
Poster

Personalized circulating tumor DNA (ctDNA) analysis in patients with recurrent/metastatic head & neck squamous cell cancer (R/M HNSCC)

ASCO 2022
Presented
Jun 6, 2022
Type
Poster

Dissection of the expressed actionable fusions’ repertoire in solid tumors tested serially in the clinical setting across 14 cancer types

ASCO 2022
Presented
Jun 5, 2022
Type
Abstract

Plasma first: Accelerating lung cancer diagnosis through liquid biopsy

ASCO 2022
Presented
Jun 5, 2022
Type
Poster

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer

Presented
Jun 4, 2022
Type
Publication

Predicting pathological response after ipilimumab plus nivolumab in stage III urothelial cancer by liquid-biopsy assessment of plasma and urine ctDNA using the RaDaR assay

ASCO 2022
Presented
Jun 4, 2022
Type
Poster

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients